A theoretical framework informing research about the role of stress in the pathophysiology of bipolar disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 39, Issue 1, 2012, Pages 1-8

  Brietzke, Elisa ^a   Mansur, Rodrigo Barbachan ^a   Soczynska, Joanna ^b   Powell, Alissa M ^b   McIntyre, Roger S ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Adaptation; Bipolar disorder; Resilience; Stress

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ALLOSTASIS; ANALYTIC METHOD; BIPOLAR DISORDER; BRAIN DEVELOPMENT; BRAIN FUNCTION; CLINICAL FEATURE; CONCEPTUAL FRAMEWORK; COPING BEHAVIOR; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE MODEL; DISEASE RESISTANCE; DISEASE SEVERITY; ENCEPHALITIS; GLUCOSE METABOLISM; HORMESIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN METABOLISM; MEDICAL RESEARCH; MOLECULAR MECHANICS; NEUROBIOLOGY; NEUROENDOCRINE SYSTEM; NEUROLOGIC EXAMINATION; NEUROMODULATION; NEUROPROTECTION; PATHOPHYSIOLOGY; PHENOTYPE; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; STRESS; SYSTEMATIC REVIEW;

ADAPTATION, PHYSIOLOGICAL; ALLOSTASIS; ANIMALS; BIOMEDICAL RESEARCH; BIPOLAR DISORDER; DISEASE SUSCEPTIBILITY; HORMESIS; HUMANS; MODELS, BIOLOGICAL; NEUROSECRETORY SYSTEMS; STRESS, PSYCHOLOGICAL;

EID: 84864498274     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.05.004     Document Type: Review

References (116)

1. Addington J., Cadenhead K.S., Cannon T.D., Cornblatt B., McGlashan T.H., Perkins D.O., et al. North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull 2007, 33(3):665-672.
2. Alaerts M., Del-Favero J. Searching genetic risk factors for schizophrenia and bipolar disorder: learn from the past and back to the future. Hum Mutat 2009, 30(8):1139-1152.
3. Alloy L.B., Abramson L.Y., Walshaw P.D., Keyser J., Gerstein R.K. A cognitive vulnerability-stress perspective on bipolar spectrum disorders in a normative adolescent brain, cognitive, and emotional development context. Dev Psychopathol 2006, 18(4):1055-1103.
4. Altman S., Haeri S., Cohen L.J., Ten A., Barron E., Galynker I.I., et al. Predictors of relapse in bipolar disorder: a review. J Psychiatr Pract 2006, 12(5):269-282.
5. Anacker C., Zunszain P.A., Carvalho L.A., Pariante C.M. The glucocorticoid receptor: pivot of depression and of antidepressant treatment?. Psychoneuroendocrinology 2011, 36(3):415-425.
6. Angst J., Gamma A., Lewinsohn P. The evolving epidemiology of bipolar disorder. World Psychiatry 2002, 1(3):146-148.
7. Axelrod D., Burns K., Davis D., von Larebeke N. "Hormesis"-an inappropriate extrapolation from the specific to the universal. Int J Occup Environ Health 2004, 10(3):335-339.
8. Becker B.A. The phenomenon of stress: concepts and mechanisms associated with stress-induced responses of the neuroendocrine system. Vet Res Commun 1987, 11(5):443-456.
9. Bender R.E., Alloy L.B. Life stress and kindling in bipolar disorder: review of the evidence and integration with emerging biopsychosocial theories. Clin Psychol Rev 2011, 31(3):383-398.
10. Berton O., McClung C.A., Dileone R.J., Krishnan V., Renthal W., Russo S.J., et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006, 311(5762):864-868.
11. Bleuler M. Conception of schizophrenia within the last fifty years and today. Proc R Soc Med 1963, 56:945-952.
12. Brietzke E., Kapczinski F. TNF-alpha as a molecular target in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32(6):1355-1361.
13. Brietzke E., Kapczinski F., Grassi-Oliveira R., Grande I., Vieta E., McIntyre R.S. Insulin dysfunction and allostatic load in bipolar disorder. Expert Rev Neurother 2011, 11(7):1017-1028.
14. Brietzke E., Stabellini R., Grassis-Oliveira R., Lafer B. Cytokines in bipolar disorder: recent findings, deleterious effects but promise for future therapeutics. CNS Spectr 2011.
15. Buckley P.F., Pillai A., Howell K.R. Brain-derived neurotrophic factor: findings in schizophrenia. Curr Opin Psychiatry 2011, 24(2):122-127.
16. Calabrese E.J. Hormesis-basic, generalizable, central to toxicology and a method to improve the risk-assessment process. Int J Occup Environ Health 2004, 10(4):466-467.
17. Campolongo P., Trezza V., Ratano P., Palmery M., Cuomo V. Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents. Psychopharmacology (Berl) 2011, 214(1):5-15.
18. Cannon W.B. The interrelations of emotions as suggested by recent physiological researches. Am J Psychology 1914, 25(2):256.
19. Canon W.B. Organization for physiological homeostasis. Physiol Rev 1929, 9:399-431.
20. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301(5631):386-389.
21. Catalani A., Alema G.S., Cinque C., Zuena A.R., Casolini P. Maternal corticosterone effects on hypothalamus-pituitary-adrenal axis regulation and behavior of the offspring in rodents. Neurosci Biobehav Rev 2011, 35(7):1502-1517.
22. Chen L.P., Murad M.H., Paras M.L., Colbenson K.M., Sattler A.L., Goranson E.N., et al. Sexual abuse and lifetime diagnosis of psychiatric disorders: systematic review and meta-analysis. Mayo Clin Proc 2010, 85(7):618-629.
23. Cohen M., Solowij N., Carr V. Cannabis, cannabinoids and schizophrenia: integration of the evidence. Aust N Z J Psychiatry 2008, 42(5):357-368.
24. Conrad M., Hubold C., Fischer B., Peters A. Modeling the hypothalamus-pituitary-adrenal system: homeostasis by interacting positive and negative feedback. J Biol Phys 2009, 35(2):149-162.
25. Correll C.U., Hauser M., Auther A.M., Cornblatt B.A. Research in people with psychosis risk syndrome: a review of the current evidence and future directions. J Child Psychol Psychiatry 2010, 51(4):390-431.
26. Cotman C.W., Scheff S.W. Compensatory synapse growth in aged animals after neuronal death. Mech Ageing Dev 1979, 9(1-2):103-117.
27. Cunha A.B., Frey B.N., Andreazza A.C., Goi J.D., Rosa A.R., Goncalves C.A., et al. Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett 2006, 398(3):215-219.
28. Danese A., Pariante C.M., Caspi A., Taylor A., Poulton R. Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci U S A 2007, 104(4):1319-1324.
29. Daruy-Filho L., Brietzke E., Lafer B., Grassi-Oliveira R. Childhood maltreatment and clinical outcomes of bipolar disorder. Acta Psychiatr Scand 2011, 124(6):427-434.
30. De Kloet E.R., Vreugdenhil E., Oitzl M.S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998, 19(3):269-301.
31. de Oliveira G.S., Cereser K.M., Fernandes B.S., Kauer-Sant'Anna M., Fries G.R., Stertz L., et al. Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. J Psychiatr Res 2009, 43(14):1171-1174.
32. Dekel S., Mandl C., Solomon Z. Shared and unique predictors of post-traumatic growth and distress. J Clin Psychol 2011, 67(3):241-252.
33. Dell'osso L., Carmassi C., Del Debbio A., Dell'osso M.C., Bianchi C., da Pozzo E., et al. Brain-derived neurotrophic factor plasma levels in patients suffering from post-traumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33(5):899-902.
34. DeRijk R.H., Wust S., Meijer O.C., Zennaro M.C., Federenko I.S., Hellhammer D.H., et al. A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness. J Clin Endocrinol Metab 2006, 91(12):5083-5089.
35. Elzinga B.M., Molendijk M.L., Oude Voshaar R.C., Bus B.A., Prickaerts J., Spinhoven P., et al. The impact of childhood abuse and recent stress on serum brain-derived neurotrophic factor and the moderating role of BDNF Val66Met. Psychopharmacology (Berl) 2011, 214(1):319-328.
36. Erb S. Evaluation of the relationship between anxiety during withdrawal and stress-induced reinstatement of cocaine seeking. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34(5):798-807.
37. Fleming J., Ledogar R.J. Resilience, an evolving concept: a review of literature relevant to aboriginal research. Pimatisiwin 2008, 6(2):7-23.
38. Fox H.C., Jackson E.D., Sinha R. Elevated cortisol and learning and memory deficits in cocaine dependent individuals: relationship to relapse outcomes. Psychoneuroendocrinology 2009, 34(8):1198-1207.
39. Frank M.G., Benington J.H. The role of sleep in memory consolidation and brain plasticity: dream or reality?. Neuroscientist 2006, 12(6):477-488.
40. Fride E., Gobshtis N., Dahan H., Weller A., Giuffrida A., Ben-Shabat S. The endocannabinoid system during development: emphasis on perinatal events and delayed effects. Vitam Horm 2009, 81:139-158.
41. Frodl T., Reinhold E., Koutsouleris N., Reiser M., Meisenzahl E.M. Interaction of childhood stress with hippocampus and prefrontal cortex volume reduction in major depression. J Psychiatr Res 2010, 44(13):799-807.
42. Gatt J.M., Nemeroff C.B., Dobson-Stone C., Paul R.H., Bryant R.A., Schofield P.R., et al. Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol Psychiatry 2009, 14(7):681-695.
43. Gorzalka B.B., Hill M.N., Hillard C.J. Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders. Neurosci Biobehav Rev 2008, 32(6):1152-1160.
44. Hill M.N., Karatsoreos I.N., Hillard C.J., McEwen B.S. Rapid elevations in limbic endocannabinoid content by glucocorticoid hormones in vivo. Psychoneuroendocrinology 2010, 35(9):1333-1338.
45. Hill M.N., McEwen B.S. Endocannabinoids: the silent partner of glucocorticoids in the synapse. Proc Natl Acad Sci U S A 2009, 106(12):4579-4580.
46. Hill M.N., McEwen B.S. Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34(5):791-797.
47. Hill M.N., Patel S., Campolongo P., Tasker J.G., Wotjak C.T., Bains J.S. Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output. J Neurosci 2010, 30(45):14980-14986.
48. Hillegers M.H., Burger H., Wals M., Reichart C.G., Verhulst F.C., Nolen W.A., et al. Impact of stressful life events, familial loading and their interaction on the onset of mood disorders: study in a high-risk cohort of adolescent offspring of parents with bipolar disorder. Br J Psychiatry 2004, 185:97-101.
49. Hitze B., Hubold C., van Dyken R., Schlichting K., Lehnert H., Entringer S., et al. How the selfish brain organizes its supply and demand. Front Neuroenergetics 2010, 2:7.
50. Horesh N., Apter A., Zalsman G. Timing, quantity and quality of stressful life events in childhood and preceding the first episode of bipolar disorder. J Affect Disord 2011, 134(1-3):434-437.
51. Horesh N., Iancu I. A comparison of life events in patients with unipolar disorder or bipolar disorder and controls. Compr Psychiatry 2010, 51(2):157-164.
52. Hu P., Stylos-Allan M., Walker M.P. Sleep facilitates consolidation of emotional declarative memory. Psychol Sci 2006, 17(10):891-898.
53. Kaidanovich-Beilin O., Lipina T.V., Takao K., van Eede M., Hattori S., Laliberte C., et al. Abnormalities in brain structure and behavior in GSK-3alpha mutant mice. Mol Brain 2009, 2:35.
54. Kapczinski F., Dal-Pizzol F., Teixeira A.L., Magalhaes P.V., Kauer-Sant'Anna M., Klamt F., et al. Peripheral biomarkers and illness activity in bipolar disorder. J Psychiatr Res 2011, 45(2):156-161.
55. Kapczinski F., Dias V.V., Kauer-Sant'Anna M., Frey B.N., Grassi-Oliveira R., Colom F., et al. Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother 2009, 9(7):957-966.
56. Kapczinski F., Vieta E., Andreazza A.C., Frey B.N., Gomes F.A., Tramontina J., et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev 2008, 32(4):675-692.
57. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62(6):593-602.
58. Ketter T.A. Diagnostic features, prevalence, and impact of bipolar disorder. J Clin Psychiatry 2010, 71(6):e14.
59. Kim E.Y., Miklowitz D.J., Biuckians A., Mullen K. Life stress and the course of early-onset bipolar disorder. J Affect Disord 2007, 99(1-3):37-44.
60. Klosterkotter J., Hellmich M., Steinmeyer E.M., Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001, 58(2):158-164.
61. Krishnan V., Han M.H., Graham D.L., Berton O., Renthal W., Russo S.J., et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 2007, 131(2):391-404.
62. Kubera M., Obuchowicz E., Goehler L., Brzeszcz J., Maes M. In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35(3):744-759.
63. Lai M.C., Huang L.T. Effects of early life stress on neuroendocrine and neurobehavior: mechanisms and implications. Pediatr Neonatol 2011, 52(3):122-129.
64. Llorente-Berzal A., Fuentes S., Gagliano H., Lopez-Gallardo M., Armario A., Viveros M.P., et al. Sex-dependent effects of maternal deprivation and adolescent cannabinoid treatment on adult rat behaviour. Addict Biol 2011, 16(4):624-637.
65. Madsen P.L., Hasselbalch S.G., Hagemann L.P., Olsen K.S., Bulow J., Holm S., et al. Persistent resetting of the cerebral oxygen/glucose uptake ratio by brain activation: evidence obtained with the Kety-Schmidt technique. J Cereb Blood Flow Metab 1995, 15(3):485-491.
66. Magalhaes P.V., Kapczinski F., Nierenberg A.A., Deckersbach T., Weisinger D., Dodd S., et al. Illness burden and medical comorbidity in the systematic treatment enhancement program for bipolar disorder. Acta Psychiatr Scand 2012, 125(4):262-263.
67. Maquet P. Sleep function(s) and cerebral metabolism. Behav Brain Res 1995, 69(1-2):75-83.
68. Mattson M.P. Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Med 2003, 3(2):65-94.
69. Mattson M.P. Hormesis defined. Ageing Res Rev 2008, 7(1):1-7.
70. McEwen B.S. The ever-changing brain: cellular and molecular mechanisms for the effects of stressful experiences. Dev Neurobiol 2012, 72(6):878-890.
71. McEwen B.S. Mood disorders and allostatic load. Biol Psychiatry 2003, 54(3):200-207.
72. McEwen B.S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 2007, 87(3):873-904.
73. McEwen B.S. Sleep deprivation as a neurobiologic and physiologic stressor: allostasis and allostatic load. Metabolism 2006, 55(10 Suppl. 2):S20-S23.
74. McEwen B.S. Stress, sex, and neural adaptation to a changing environment: mechanisms of neuronal remodeling. Ann N Y Acad Sci 2010, 1204:E38-E59. (Suppl.).
75. McEwen B.S., Eiland L., Hunter R.G., Miller M.M. Stress and anxiety: structural plasticity and epigenetic regulation as a consequence of stress. Neuropharmacology 2012, 62(1):3-12.
76. McEwen B.S., Stellar E. Stress and the individual. Mechanisms leading to disease. Arch Intern Med 1993, 153(18):2093-2101.
77. McGuffin P., Rijsdijk F., Andrew M., Sham P., Katz R., Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 2003, 60(5):497-502.
78. Merikangas K.R., Jin R., He J.P., Kessler R.C., Lee S., Sampson N.A., et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011, 68(3):241-251.
79. Monroe S.M., Simons A.D. Diathesis-stress theories in the context of life stress research: implications for the depressive disorders. Psychol Bull 1991, 110(3):406-425.
80. Neigh G.N., Gillespie C.F., Nemeroff C.B. The neurobiological toll of child abuse and neglect. Trauma Violence Abuse 2009, 10(4):389-410.
81. Neves-Pereira M., Mundo E., Muglia P., King N., Macciardi F., Kennedy J.L. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 2002, 71(3):651-655.
82. Nguyen K.T., Deak T., Owens S.M., Kohno T., Fleshner M., Watkins L.R., et al. Exposure to acute stress induces brain interleukin-1beta protein in the rat. J Neurosci 1998, 18(6):2239-2246.
83. Nucifora F., Langlieb A.M., Siegal E., Everly G.S., Kaminsky M. Building resistance, resilience, and recovery in the wake of school and workplace violence. Disaster Med Public Health Prep 2007, 1(1 Suppl.):S33-S37.
84. Nugent N.R., Tyrka A.R., Carpenter L.L., Price L.H. Gene-environment interactions: early life stress and risk for depressive and anxiety disorders. Psychopharmacology (Berl) 2011, 214(1):175-196.
85. Oberlander T.F., Weinberg J., Papsdorf M., Grunau R., Misri S., Devlin A.M. Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics 2008, 3(2):97-106.
86. Oitzl M.S., Champagne D.L., van der Veen R., de Kloet E.R. Brain development under stress: hypotheses of glucocorticoid actions revisited. Neurosci Biobehav Rev 2010, 34(6):853-866.
87. Ozgurdal S., van Haren E., Hauser M., Strohle A., Bauer M., Assion H.J., et al. Early mood swings as symptoms of the bipolar prodrome: preliminary results of a retrospective analysis. Psychopathology 2009, 42(5):337-342.
88. Pacak K., Palkovits M. Stressor specificity of central neuroendocrine responses: implications for stress-related disorders. Endocr Rev 2001, 22(4):502-548.
89. Patton G.C., Coffey C., Carlin J.B., Degenhardt L., Lynskey M., Hall W. Cannabis use and mental health in young people: cohort study. BMJ 2002, 325(7374):1195-1198.
90. Pitman R.K., Sanders K.M., Zusman R.M., Healy A.R., Cheema F., Lasko N.B., et al. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry 2002, 51(2):189-192.
91. Post R.M. Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J Psychiatr Res 2007, 41(12):979-990.
92. Post R.M., Leverich G.S. The role of psychosocial stress in the onset and progression of bipolar disorder and its comorbidities: the need for earlier and alternative modes of therapeutic intervention. Dev Psychopathol 2006, 18(4):1181-1211.
93. Post R.M., Weiss S.R. A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures. Mol Neurobiol 1996, 13(1):33-60.
94. Radak Z., Chung H.Y., Koltai E., Taylor A.W., Goto S. Exercise, oxidative stress and hormesis. Ageing Res Rev 2008, 7(1):34-42.
95. Sapolsky R.M. Stress and plasticity in the limbic system. Neurochem Res 2003, 28(11):1735-1742.
96. Schulkin J. Allostasis: a neural behavioral perspective. Horm Behav 2003, 43(1):21-27. [discussion 28-30].
97. Sears C., Markie D., Olds R., Fitches A. Evidence of associations between bipolar disorder and the brain-derived neurotrophic factor (BDNF) gene. Bipolar Disord 2011, 13(7-8):630-637.
98. Selye H. Forty years of stress research: principal remaining problems and misconceptions. Can Med Assoc J 1976, 115(1):53-56.
99. Sterling P., Eyer J. Allostasis: a new paradigm to explain arousal pathology. Handbook of life stress, cognition and health 1988, John Wiley & Sons, New York. S. Fisher, J. Reason (Eds.).
100. Stickgold R. Sleep-dependent memory consolidation. Nature 2005, 437(7063):1272-1278.
101. Stickgold R., Walker M.P. Sleep-dependent memory consolidation and reconsolidation. Sleep Med 2007, 8(4):331-343.
102. Stiller A.L., Drugan R.C., Hazi A., Kent S.P. Stress resilience and vulnerability: the association with rearing conditions, endocrine function, immunology, and anxious behavior. Psychoneuroendocrinology 2011, 36(9):1383-1395.
103. Southam C.M., Ehrlich J. Effects of Extract of western red-cedar heartwood on certain wood-decaying fungi in culture. Phytopathology 1943, 33(9):517-524.
104. Tasker J.G. Rapid glucocorticoid actions in the hypothalamus as a mechanism of homeostatic integration. Obesity (Silver Spring) 2006, 14(Suppl. 5):259S-265S.
105. Taylor M., Bressan R.A., Pan Neto P., Brietzke E. Early intervention for bipolar disorder: current imperatives, future directions. Rev Bras Psiquiatr 2011, 33:S213-S217.
106. Tedeschi R.G., Calhoun L.G. The Posttraumatic Growth Inventory: measuring the positive legacy of trauma. J Trauma Stress 1996, 9(3):455-471.
107. van Winkel R., Stefanis N.C., Myin-Germeys I. Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr Bull 2008, 34(6):1095-1105.
108. van Zuiden M., Geuze E., Willemen H.L., Vermetten E., Maas M., Heijnen C.J., et al. Pre-existing high glucocorticoid receptor number predicting development of posttraumatic stress symptoms after military deployment. Am J Psychiatry 2011, 168(1):89-96.
109. Vitkovic L., Bockaert J., Jacque C. "Inflammatory" cytokines: neuromodulators in normal brain?. J Neurochem 2000, 74(2):457-471.
110. Wager-Smith K., Markou A. Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition?. Neurosci Biobehav Rev 2011, 35(3):742-764.
111. Wagner U., Degirmenci M., Drosopoulos S., Perras B., Born J. Effects of cortisol suppression on sleep-associated consolidation of neutral and emotional memory. Biol Psychiatry 2005, 58(11):885-893.
112. Weaver I.C., Cervoni N., Champagne F.A., D'Alessio A.C., Sharma S., Seckl J.R., et al. Epigenetic programming by maternal behavior. Nat Neurosci 2004, 7(8):847-854.
113. Wise L.A., Palmer J.R., Rothman E.F., Rosenberg L. Childhood abuse and early menarche: findings from the black women's health study. Am J Public Health 2009, 99(Suppl. 2):S460-S466.
114. Yirmiya R., Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun 2011, 25(2):181-213.
115. Yung A.R., Phillips L.J., Yuen H.P., Francey S.M., McFarlane C.A., Hallgren M., et al. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res 2003, 60(1):21-32.
116. Zohar J., Juven-Wetzler A., Sonnino R., Cwikel-Hamzany S., Balaban E., Cohen H. New insights into secondary prevention in post-traumatic stress disorder. Dialogues Clin Neurosci 2011, 13(3):301-309.